Personal Genome Diagnostics is the first company to obtain a license to materials from a unique community registry and biorepository managed by Duke CTSI.
The license marks a milestone for the MURDOCK Study, a longitudinal population health research program that enrolled its first participant in 2009. The registry and biorepository include samples and associated data from over 12,000 participants, based at CTSI’s Duke Kannapolis research site, now a part of the new Center for Precision Health (CPH).
Licensing in support of industry research and development, in collaboration with the Duke Office of Translation and Commercialization (OTC), is one of a broad range of uses of the registry available through the Biorepository Transformation Initiative. This initiative makes thousands of biospecimens and associated clinical outcomes data available to researchers both inside and outside of Duke. Duke investigators can easily explore the cohort with just a few clicks using the data exploration tool. The storefronts summarize data and samples at a glance for all interested researchers.
Through the initiative, Duke investigators have recently advanced biomarker research in the areas of heart failure, Alzheimer’s, and diabetes, and the Duke School of Nursing has obtained over 20,000 biological samples and linked data to advance research in health equity and social drivers of health.
As a first step toward accessing samples for academic collaboration or commercial scientific exploration, researchers can complete this brief interest form.
About Duke Kannapolis
A part of the Center for Precision Health within the Duke CTSI, Duke Kannapolis functions as an engine to accelerate precision genomics and population health research, featuring a diverse community of engaged research participants and supporting the Duke research community and external collaborators and partners. Learn more about Duke Kannapolis and the Kannapolis Population Based Cohort.